Efalizumab is a humanized antibody to the CD11 subunit of LFA-1 that inhibits the interaction of LFA-1 with its counter-receptors, including ICAM-1. It can interfere with the activation of T lymphocytes, as well as migration of cells from the circulation to sites of inflammation. It has been approved for treatment of psoriasis (Lebwohl et al. 2003). In a 12-week trial of patients with PsA, in which efalizumab was administered subcutaneously once a week, 28% of patients achieved an ACR 20 response versus 19% in the placebo group (p = 0.2717) (Papp et al. 2004). Because there was not statistically significant differentiation between the treatment group and placebo, this agent cannot currently be recommended to control arthritis in a psoriasis patient.

Was this article helpful?

0 0
Natural Arthritis Pain Remedies

Natural Arthritis Pain Remedies

It's time for a change. Finally A Way to Get Pain Relief for Your Arthritis Without Possibly Risking Your Health in the Process. You may not be aware of this, but taking prescription drugs to get relief for your Arthritis Pain is not the only solution. There are alternative pain relief treatments available.

Get My Free Ebook

Post a comment